12 brands based in Rahway. Discover which parent companies own these brands.
Healthcare PharmaceuticalsOwned by Merck & Co.
Prescription medication for reversing neuromuscular blockade during anesthesia, manufactured and marketed by Merck & Co.
Healthcare PharmaceuticalsOwned by Unknown Company
Prescription blood pressure medication, the first angiotensin II receptor blocker, approved by the FDA in 1995.
Healthcare PharmaceuticalsOwned by Merck & Co.
Prescription human papillomavirus vaccine for preventing cervical cancer and other HPV-related cancers, manufactured and marketed by Merck & Co.
Healthcare PharmaceuticalsOwned by Merck & Co.
Prescription antiretroviral medication for treating HIV infection by inhibiting integrase enzyme, manufactured and marketed by Merck & Co.
Healthcare PharmaceuticalsOwned by Merck & Co.
Prescription diabetes medication for treating type 2 diabetes by increasing insulin secretion, manufactured and marketed by Merck & Co.
Healthcare PharmaceuticalsOwned by Merck & Co.
Prescription immunotherapy medication for treating various cancers by activating the immune system, manufactured and marketed by Merck & Co.
Healthcare PharmaceuticalsOwned by Merck & Co.
Over-the-counter and prescription medication for treating heartburn and acid reflux, manufactured and marketed by Merck & Co.
Healthcare PharmaceuticalsOwned by Merck & Co.
Merck's 23-valent pneumococcal polysaccharide vaccine (PPSV23), FDA approved in 1983 as an expansion of Merck's 14-valent formulation licensed in 1977, providing T-cell independent immune protection against 23 pneumococcal serotypes in adults aged 50 and older and high-risk individuals, now used alongside conjugate vaccines per updated CDC recommendations.
Healthcare PharmaceuticalsOwned by Merck & Co.
Prescription medication for treating male pattern baldness by inhibiting hair loss, manufactured and marketed by Merck & Co.
Healthcare PharmaceuticalsOwned by Merck & Co.
Merck's live oral pentavalent rotavirus vaccine (RV5), FDA approved February 3, 2006, developed by Paul Offit and colleagues at Children's Hospital of Philadelphia, containing five human-bovine reassortant rotavirus strains (G1, G2, G3, G4, and P1A) administered as a 3-dose oral series to infants, recommended by the CDC for routine infant immunization.
Healthcare PharmaceuticalsOwned by Merck & Co.
Prescription medication for treating asthma and allergies by reducing inflammation in the airways, manufactured and marketed by Merck & Co.
Healthcare PharmaceuticalsOwned by Merck & Co.
Prescription combination medication for treating high blood pressure, manufactured and marketed by Merck & Co.